+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hospital Infection Therapeutics Market by Drug Class, Route of Administration, End User, Distribution Channel, Application - Global Forecast to 2030- Product Image
Hospital Infection Therapeutics Market by Drug Class, Route of Administration, End User, Distribution Channel, Application - Global Forecast to 2030- Product Image
Sale

Hospital Infection Therapeutics Market by Drug Class, Route of Administration, End User, Distribution Channel, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4905131
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The hospital infection therapeutics market is rapidly transforming in response to rising antimicrobial resistance, technological innovation, and changing global healthcare landscapes. Strategic decision-makers must continuously align their organizations with evolving treatment paradigms and regulatory developments to maintain competitive positioning.

Market Snapshot: Hospital Infection Therapeutics

The Hospital Infection Therapeutics Market grew from USD 6.38 billion in 2024 to USD 6.92 billion in 2025. It is expected to continue growing at a CAGR of 8.30%, reaching USD 10.30 billion by 2030.

Scope & Segmentation

This report delivers in-depth analysis across all key dimensions shaping the hospital infection therapeutics landscape:

  • Drug Classes: Antibiotics (carbapenems, cephalosporins, fluoroquinolones, macrolides, penicillins), antifungals (azoles, echinocandins, polyenes), antiseptics (alcohol-based, chlorhexidine, iodophors), antivirals (anti-HBV, anti-HCV, anti-HIV, anti-influenza).
  • Routes of Administration: Inhalation, oral, all parenteral types (intramuscular, intravenous, subcutaneous), topical.
  • End Users: Ambulatory surgery centers, clinics, home healthcare, hospitals.
  • Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy, wholesalers.
  • Clinical Applications: Palliative, prophylaxis (pre- and post-operative), treatment (empirical and targeted therapy).
  • Geographies Covered: Americas (United States with major states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Players Profiled: Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, Sanofi S.A., F. Hoffmann-La Roche Ltd, Novartis AG, Bayer AG, AbbVie Inc., Astellas Pharma Inc.

Key Takeaways: Strategic Insights for Senior Leaders

  • Rapid diagnostic platforms and advanced data analytics are enhancing infection identification and streamlining therapeutic interventions, reducing empiric therapy reliance in acute care.
  • Integrated stewardship frameworks and evolving reimbursement models are prompting hospitals to recalibrate budgets, incentivizing faster cure rates and outcome-based care protocols.
  • Combination therapies, including novel lipid-based and polymer-conjugated formulations, are gaining traction, reflecting a trend toward multi-targeted and patient-centric approaches.
  • Regional differences in epidemiology, policy, and investment are shaping adoption rates and R&D pipelines, driving tailored strategies in the Americas, EMEA, and Asia-Pacific.
  • Strategic alliances and partnerships, particularly between large pharmaceutical firms and biotech innovators, are fueling portfolio diversification and strengthening post-market evidence generation.

Tariff Impact on Therapeutic Access

Recent policy-driven tariffs on imported pharmaceutical ingredients and finished products are impacting hospital procurement and manufacturing. The resulting cost pressures and supply fluctuations are accelerating domestic production initiatives and prompting flexible supplier agreements. Pharmaceutical R&D is increasingly directed toward molecules and formulations insulated from import duties or based on alternative synthesis pathways. Adaptive contracting and sourcing strategies are essential for maintaining product availability and affordability.

Methodology & Data Sources

This analysis is built on a multi-phase research process combining primary interviews with over eighty stakeholders, in-depth secondary review of industry documents, clinical trial outcomes, and regulatory reports. Quantitative market data were validated through statistical modeling and triangulated with insights from health databases and commercial platforms. Rigorous scenario testing and peer review ensure robust, actionable findings.

Why This Report Matters

  • Enables executive teams to assess risks and opportunities from industry shifts, regulatory trends, and technological advances—ensuring resilient, future-forward strategic planning.
  • Provides board-ready insights on market segmentation, access dynamics, and geographic performance—supporting investment decisions and operational resource allocation.
  • Highlights the convergence of diagnostic innovation, advanced therapeutics, and value-based care, offering a clear context for R&D, procurement, and policy engagement strategies.

Conclusion

The hospital infection therapeutics market is defined by ongoing scientific progress, evolving policy environments, and dynamic regional shifts. Effective navigation requires data-driven insight and a cohesive response to both clinical and market complexities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Hospital Infection Therapeutics Market, by Drug Class
8.1. Introduction
8.2. Antibiotics
8.2.1. Carbapenems
8.2.2. Cephalosporins
8.2.3. Fluoroquinolones
8.2.4. Macrolides
8.2.5. Penicillins
8.3. Antifungals
8.3.1. Azoles
8.3.2. Echinocandins
8.3.3. Polyenes
8.4. Antiseptics
8.4.1. Alcohol Based
8.4.2. Chlorhexidine
8.4.3. Iodophors
8.5. Antivirals
8.5.1. Anti-HBV
8.5.2. Anti-HCV
8.5.3. Anti-HIV
8.5.4. Anti-Influenza
9. Hospital Infection Therapeutics Market, by Route of Administration
9.1. Introduction
9.2. Inhalation
9.3. Oral
9.4. Parenteral
9.4.1. Intramuscular
9.4.2. Intravenous
9.4.3. Subcutaneous
9.5. Topical
10. Hospital Infection Therapeutics Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Clinics
10.4. Home Healthcare
10.5. Hospitals
11. Hospital Infection Therapeutics Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
11.5. Wholesalers
12. Hospital Infection Therapeutics Market, by Application
12.1. Introduction
12.2. Palliative
12.3. Prophylaxis
12.3.1. Post-Operative
12.3.2. Pre-Operative
12.4. Treatment
12.4.1. Empirical
12.4.2. Targeted Therapy
13. Americas Hospital Infection Therapeutics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Hospital Infection Therapeutics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Hospital Infection Therapeutics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. Merck & Co., Inc.
16.3.3. GlaxoSmithKline plc
16.3.4. Johnson & Johnson
16.3.5. Sanofi S.A.
16.3.6. F. Hoffmann-La Roche Ltd
16.3.7. Novartis AG
16.3.8. Bayer AG
16.3.9. AbbVie Inc.
16.3.10. Astellas Pharma Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HOSPITAL INFECTION THERAPEUTICS MARKET MULTI-CURRENCY
FIGURE 2. HOSPITAL INFECTION THERAPEUTICS MARKET MULTI-LANGUAGE
FIGURE 3. HOSPITAL INFECTION THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. HOSPITAL INFECTION THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. HOSPITAL INFECTION THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. HOSPITAL INFECTION THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY CARBAPENEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY AZOLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ECHINOCANDINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY POLYENES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ALCOHOL BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY CHLORHEXIDINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY IODOPHORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTI-HBV, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTI-HCV, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTI-HIV, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTI-INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY WHOLESALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PALLIATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY POST-OPERATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PRE-OPERATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY EMPIRICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 85. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 86. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 87. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 88. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 89. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 90. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 91. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 92. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 96. CANADA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 98. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 99. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 100. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 102. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 104. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 108. MEXICO HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 158. GERMANY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 159. GERMANY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 160. GERMANY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 161. GERMANY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 162. GERMANY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 163. GERMANY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. GERMANY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 165. GERMANY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. GERMANY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. GERMANY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. GERMANY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 169. GERMANY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 170. FRANCE HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 171. FRANCE HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 172. FRANCE HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 173. FRANCE HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 174. FRANCE HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 175. FRANCE HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. FRANCE HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 177. FRANCE HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. FRANCE HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. FRANCE HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. FRANCE HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 181. FRANCE HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 194. ITALY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 195. ITALY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 196. ITALY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 197. ITALY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 198. ITALY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 199. ITALY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 200. ITALY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 201. ITALY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. ITALY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. ITALY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. ITALY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 205. ITALY HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 206. SPAIN HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 207. SPAIN HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 208. SPAIN HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 209. SPAIN HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 210. SPAIN HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 211. SPAIN HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 212. SPAIN HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 213. SPAIN HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. SPAIN HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. SPAIN HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. SPAIN HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 217. SPAIN HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 254. DENMARK HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 255. DENMARK HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 256. DENMARK HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 257. DENMARK HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 258. DENMARK HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 259. DENMARK HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 260. DENMARK HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 261. DENMARK HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. DENMARK HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. DENMARK HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. DENMARK HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 265. DENMARK HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 273. NETHERLANDS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. NETHERLANDS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 275. NETHERLANDS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. NETHERLANDS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 277. NETHERLANDS HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 278. QATAR HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 279. QATAR HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 280. QATAR HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 281. QATAR HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 282. QATAR HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 283. QATAR HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 284. QATAR HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 285. QATAR HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. QATAR HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 287. QATAR HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. QATAR HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 289. QATAR HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 290. FINLAND HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 291. FINLAND HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 292. FINLAND HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 293. FINLAND HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTISEPTICS, 2018-2030 (USD MILLION)
TABLE 294. FINLAND HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 295. FINLAND HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 296. FINLAND HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 297. FINLAND HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. FINLAND HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. FINLAND HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. FINLAND HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY PROPHYLAXIS, 2018-2030 (USD MILLION)
TABLE 301. FINLAND HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN HOSPITAL INFECTION THERAPEUTICS MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 305. SWEDEN HOSPITAL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Hospital Infection Therapeutics market report include:
  • Pfizer Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Sanofi S.A.
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Bayer AG
  • AbbVie Inc.
  • Astellas Pharma Inc.

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.92 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.3 Billion
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Respiratory Tract Infection Therapeutic Market by Therapeutic Type, Infection Type, Route Of Administration, Patient Type, Distribution Channel - Global Forecast to 2030 - Product Image

Respiratory Tract Infection Therapeutic Market by Therapeutic Type, Infection Type, Route Of Administration, Patient Type, Distribution Channel - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Hospital Infection Therapeutics Market 2025-2029 - Product Image

Hospital Infection Therapeutics Market 2025-2029

  • Report
  • 231 Pages
  • Global
From
Hospital Infection Therapeutics Market Report by Drug Type, Indication, and Region 2024-2032 - Product Image

Hospital Infection Therapeutics Market Report by Drug Type, Indication, and Region 2024-2032

  • Report
  • 140 Pages
  • Global
From
Hospital Acquired Infection Treatment - Global Strategic Business Report - Product Image

Hospital Acquired Infection Treatment - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Urinary Tract Infection Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Urinary Tract Infection Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 112 Pages
  • Global
From

About the Hospital Acquired Infection Drug Market

The Hospital Acquired Infection Drug market is a subset of the Infectious Diseases Drugs market. It focuses on drugs used to treat infections acquired in a hospital setting, such as Methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (C. diff). These drugs are typically antibiotics, antivirals, antifungals, and antiparasitics. They are used to treat infections that are resistant to traditional treatments, or to prevent infections in patients with weakened immune systems. The Hospital Acquired Infection Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bayer. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.